Paul Tudor Jones Artivion, Inc. Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Artivion, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 107,409 shares of AORT stock, worth $4.25 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
107,409
Previous 234,989
54.29%
Holding current value
$4.25 Million
Previous $5.78 Million
42.17%
% of portfolio
0.01%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding AORT
# of Institutions
193Shares Held
40.2MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$263 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$117 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$111 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$111 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.32MShares$91.7 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.59B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...